Sanofi Files U.S. Suit Against Merck & Co. Over Patents
French pharmaceutical giant Sanofi SA (SAN.FR) Monday said it filed a lawsuit against Merck & Co.'s international unit for alleged patent infringements.
In the filing in the U.S. district court of Delaware, Sanofi said it claims that Merck Sharp & Dohme Corp. violated as many as 10 patents held by the French company, including ones for its blockbuster diabetes treatment Lantus and its insulin delivery device soloSTAR.
In the filing in the U.S. district court of Delaware, Sanofi said it claims that Merck Sharp & Dohme Corp. violated as many as 10 patents held by the French company, including ones for its blockbuster diabetes treatment Lantus and its insulin delivery device soloSTAR.